These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25788956)

  • 41. Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients.
    Gandhe SS; Chadha MS; Walimbe AM; Arankalle VA
    J Viral Hepat; 2003 Sep; 10(5):367-82. PubMed ID: 12969189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants.
    Gao S; Joshi SS; Osiowy C; Chen Y; Coffin CS; Duan ZP
    Virol J; 2017 Oct; 14(1):203. PubMed ID: 29065883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B.
    Lin CL; Liao LY; Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
    J Gastroenterol; 2002; 37(4):283-7. PubMed ID: 11993512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
    Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
    J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers.
    Mello FM; Kuniyoshi AS; Lopes AF; Gomes-Gouvêa MS; Bertolini DA
    Rev Soc Bras Med Trop; 2014; 47(6):701-8. PubMed ID: 25626648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.
    Kuhnhenn L; Jiang B; Kubesch A; Vermehren J; Knop V; Susser S; Dietz J; Carra G; Finkelmeier F; Grammatikos G; Zeuzem S; Sarrazin C; Hildt E; Peiffer KH
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1523-1535. PubMed ID: 29637585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.
    Yan L; Zhang H; Ma H; Liu D; Li W; Kang Y; Yang R; Wang J; He G; Xie X; Wang H; Wei L; Lu Z; Shao Q; Chen H
    Sci Rep; 2015 Dec; 5():17950. PubMed ID: 26647737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients.
    Shokatpour N; Vaezjalali M; Foster GR; Sali S
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019046. PubMed ID: 31308922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B.
    Liu Y; Zhong Y; Zou Z; Xu Z; Li B; Ren X; Bai S; Wang L; Li X; Dai J; Wang Y; Mao P; Xu D
    J Clin Virol; 2010 Mar; 47(3):243-7. PubMed ID: 20080060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains.
    Herbers U; Amini-Bavil-Olyaee S; Mueller A; Luedde T; Trautwein C; Tacke F
    J Viral Hepat; 2013 Feb; 20(2):141-8. PubMed ID: 23301549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels.
    Shi M; Zhang Y; Zhang J; Liu W; Xing L
    Braz J Infect Dis; 2012; 16(1):52-6. PubMed ID: 22358356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and management of pre-core mutant chronic hepatitis B.
    Papatheodoridis GV; Hadziyannis SJ
    J Viral Hepat; 2001 Sep; 8(5):311-21. PubMed ID: 11555188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of characteristics of HBV quasispecies with hepatitis B surface antigen seroconversion after pegylated interferon-α-2a treatment in child patients.
    Yang J; Yang G; He H; Ning L; Liu Z; Fu Q; Chen H; Deng H; Wang Z; Luo K
    Antivir Ther; 2018; 23(7):567-574. PubMed ID: 30095435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.